ALPHAMAB ONCOLOGY |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5 HKD | +5.26% |
|
+14.94% | -24.70% |
Chart calendar Alphamab Oncology
1b4b33ae2e3e63faa9136b9f72.WShi3XtZuUFt1Sl0HwRcIswL67PVT-x69kxGmot9mG8.LGwrkDM6_R5b4nkkaGEzQPlYnuGTLKU4sgcr9uwa6TdvSzuxNiHsNR2AYA~22568ce49485dc46499488901378a9f0
Upcoming events on Alphamab Oncology
Past events on Alphamab Oncology
| 29/03/2024 02:42 | Q4 2023 Earnings Release |
| 22/08/2023 | Q2 2023 Earnings Release |
| 30/03/2023 | Q4 2022 Earnings Release |
| 30/08/2022 | Interim 2022 Earnings Release |
| 30/03/2022 03:35 | FY 2021 Earnings Release |
| 26/08/2021 | Interim 2021 Earnings Release |
| 11/06/2021 02:00 | Annual General Meeting |
| 22/03/2021 | FY 2020 Earnings Release |
| 16/11/2020 13:00 | Bernstein Operational Decisions Conference |
| 28/08/2020 14:05 | Interim 2020 Earnings Release |
| 30/03/2020 | FY 2019 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 0,00 0,00 - | 0,00 1,50 - | 146 114 27.63% | 167 194 -14.05% | 219 223 -1.9% |
|
EBITDA Million CNY | Released Forecast Spread | -274 -368 25.36% | -398 -526 24.26% | -371 -512 27.64% | -377 -405 6.97% | -254 -256 0.62% |
|
EBIT Million CNY | Released Forecast Spread | -285 -378 24.73% | -409 -559 26.73% | -416 -557 25.4% | -432 -467 7.51% | -323 -294 -10.08% |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -833 -415 -100.66% | -428 -513 16.61% | -412 -487 15.39% | -326 -506 35.66% | -211 -365 42.29% |
|
Net income Million CNY | Released Forecast Spread | -833 -415 -100.66% | -428 -513 16.61% | -412 -472 12.61% | -326 -506 35.66% | -211 -365 42.29% |
|
EPS CNY | Released Forecast Spread | -0,93 -0,50 -85.6% | -0,46 -0,56 17.78% | -0,44 -0,56 21.24% | -0,35 -0,52 33.31% | -0,22 -0,38 42.6% |
| Announcement Date | 31/03/20 | 23/03/21 | 29/03/22 | 31/03/23 | 28/03/24 |
Quarterly results
| Fiscal Period | December | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 |
|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 44,9 4,50 897.73% | 0,00 3,30 - | 146 77,0 89.64% | 113 96,0 18% | |
|
EBIT Million CNY | Released Forecast Spread | -190 -424 55.16% | -270 -339 20.31% | -146 -432 66.31% | ||
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -325 -340 4.45% | -267 -316 15.5% | -145 -257 43.61% | -178 -335 46.74% | |
|
Net income Million CNY | Released Forecast Spread | -325 -340 4.45% | -267 -316 15.5% | -145 -420 65.42% | -147 | -178 -335 46.74% |
|
EPS CNY | Released Forecast Spread | -0,35 -0,37 5.41% | -0,29 -0,32 9.38% | -0,16 | ||
| Announcement Date | 23/03/21 | 27/08/21 | 29/03/22 | 31/08/22 | 31/03/23 |
More events
Past sector events for Alphamab Oncology
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 9966 Stock
- Calendar Alphamab Oncology
